KRISTINA MAHER: Open Payments
NPI 1366795569 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 80 payments from 24 companies in 2025. Trend: 2023 $1,882 · 2024 $1,721 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $264 |
| Novartis Pharmaceuticals Corporation | 14 | $240 |
| Novo Nordisk Inc | 8 | $186 |
| Xeris Pharmaceuticals, Inc. | 6 | $132 |
| Amgen Inc. | 6 | $111 |
| Alnylam Pharmaceuticals Inc. | 3 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $77 |
| Sequel Med Tech, LLC | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
Products named: Kerendia, LEQVIO, Wegovy, REPATHA, ONPATTRO, JARDIANCE, RECORLEV, LifeVest.
Industry payments across FL — which companies pay providers there.
